Variant report
Variant | nsv508189 |
---|---|
Chromosome Location | chr2:185695276-185701287 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs187627752 | chr2:185695305-185695306 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
2 | rs115062086 | chr2:185695318-185695319 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs370130030 | chr2:185695321-185695322 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs545114627 | chr2:185695332-185695333 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs371399048 | chr2:185695341-185695342 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs554121403 | chr2:185695351-185695352 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs538642713 | chr2:185695385-185695386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs554155848 | chr2:185695388-185695389 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs543167202 | chr2:185695403-185695404 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs561330620 | chr2:185695416-185695417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs531950338 | chr2:185695454-185695455 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543949153 | chr2:185695459-185695460 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs193088956 | chr2:185695470-185695471 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs532828915 | chr2:185695471-185695472 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs551120812 | chr2:185695506-185695507 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs554084678 | chr2:185695521-185695522 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs185736763 | chr2:185695527-185695528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs527263182 | chr2:185695628-185695629 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs572376768 | chr2:185695688-185695689 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs150589577 | chr2:185695698-185695699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs10170045 | chr2:185695719-185695720 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs16826218 | chr2:185695723-185695724 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs10181057 | chr2:185695761-185695762 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs549371804 | chr2:185695811-185695812 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs143606974 | chr2:185695851-185695852 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs553756697 | chr2:185695882-185695883 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs56200326 | chr2:185695913-185695914 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
28 | rs76585359 | chr2:185695954-185695955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555101952 | chr2:185695971-185695972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs576608152 | chr2:185695996-185695997 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs543694461 | chr2:185696006-185696007 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs565458257 | chr2:185696032-185696033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs528867955 | chr2:185696033-185696034 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs547396284 | chr2:185696034-185696035 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs374632469 | chr2:185696054-185696055 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs147720062 | chr2:185696084-185696085 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs16826219 | chr2:185696114-185696115 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
38 | rs541730852 | chr2:185696119-185696120 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs559582234 | chr2:185696128-185696129 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs12998966 | chr2:185696155-185696156 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs144278306 | chr2:185696203-185696204 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548570021 | chr2:185696237-185696238 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs72905730 | chr2:185696271-185696272 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs557884464 | chr2:185696351-185696352 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs531421348 | chr2:185696352-185696353 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs190439865 | chr2:185696358-185696359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs571443413 | chr2:185696389-185696390 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs538421867 | chr2:185696464-185696465 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs13400759 | chr2:185696467-185696468 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
50 | rs200517686 | chr2:185696475-185696476 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17603634 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Ependymoma | 16718352 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 18522746 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Breast cancer | 16272173 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Embryonal rhabdomyosarcoma | 16790082 | CNVD |
Autism | 16446308 | CNVD |
Autism | 19401682 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Lung cancer | 18438408 | CNVD |
Glioblastoma | 21080181 | CNVD |
Prostate cancer | 18632612 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Facial dysmorphism | 20548289 | CNVD |
Mental retardation | 20548289 | CNVD |
Biliary cancer | 20360734 | CNVD |
Breast cancer | 20360734 | CNVD |
Coronary artery disease | 20360734 | CNVD |
Crohn''s disease | 20360734 | CNVD |
Hypertension | 20360734 | CNVD |
Rheumatoid arthritis | 20360734 | CNVD |
Type 1 diabetes | 20360734 | CNVD |
Type 2 diabetes | 20360734 | CNVD |
Breast cancer | 21364760 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
Cancer | 21183584 | CNVD |
Sudden cardiac death | 19188705 | CNVD |
Autism | 19329560 | CNVD |
Autism | 22543975 | CNVD |
Schizophrenia | 23813976 | CNVD |
Pancreatic ductal adenocarcinoma | 19077451 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:185689600-185695400 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
2 | chr2:185695400-185697200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
3 | chr2:185696000-185697200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
4 | chr2:185697200-185699400 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
5 | chr2:185697200-185699800 | Weak transcription | iPS-18 Cell Line | embryonic stem cell |
6 | chr2:185699400-185700200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
7 | chr2:185699600-185700000 | Enhancers | ES-I3 Cell Line | embryonic stem cell |
8 | chr2:185699600-185701200 | Enhancers | Fetal Heart | heart |
9 | chr2:185699800-185700200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
10 | chr2:185699800-185700200 | Enhancers | Fetal Stomach | stomach |
11 | chr2:185699800-185700600 | Enhancers | HepG2 | liver |
12 | chr2:185700000-185700600 | Enhancers | Fetal Intestine Large | intestine |
13 | chr2:185700000-185700600 | Enhancers | Fetal Intestine Small | intestine |
14 | chr2:185700800-185701800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |